EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

L-TPS18 - Allergen immunotherapy 08

Sunday 15 Jun, 12:45 PM - 13:45 PM Glasgow, United Kingdom
Poster Zone Thematic Poster Session
Allergen-Specific Immunotherapy Is Still Rarely Used: Results of an Online Survey in Lithuania
Efficacy of sublingual immunotherapy in children with allergic rhinitis
Elevated Tryptase Levels in a Severe Asthmatic Patient Undergoing SCIT for Birch: Implications for Monitoring and Personalized Treatment
Exciting Developments in Venom Allergy Treatment: The New Ultra-Rush Protocol
Hymenoptera Venom Allergy: A Case Report on Safe Discontinuation After Five Years of Venom Immunotherapy
Impact of subcutaneous allergen immunotherapy on autoimmune disease development or exacerbations: a cross-sectional study
Online Education Increases Clinician Knowledge and Confidence in Utilizing Allergen Immunotherapy for Respiratory Allergic Disease
Reasons for declining venom immunotherapy and its burden on patients' daily lives
Renewal’s analysis of liquid sublingual immunotherapy (SLIT) treatments using iPUMP: SPEED study, a Real-Life study
Study design for the efficacy of AIT in children with mild attention deficit hyperactivity disorder complicated with HDM allergy: a prospective observational study
TOWARDS A MORE PERSONALIZED ALLERGY DIAGNOSIS APPROACH USING ALLERGY EXPLORER 2 (ALEX2, MACROARRAY DIAGNOSTICS, Vienna)
When is molecular testing necessary? Rethinking allergy diagnostics for Dermatophagoides pteronyssinus
Yeast surface display as platform for generation of nanobodies to single allergens and allergen extracts

Speakers